A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Oklahoma Children's Hospital is pioneering a targeted chemotherapy treatment for retinoblastoma, a rare eye cancer in ...

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.

Many cancer treatments were developed for adult physiology, not pediatric biology, resulting in disproportionate long-term ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

Meagan Meadows was diagnosed with stage 3 colon cancer at just 24, but she rang the bell after her last round of chemo ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

A cancer diagnosis forces us to make decisions that we never imagined ourselves making. This is especially when the regular treatments don't seem to be working. Faced with a recurrence of her cancer ...